Researcher
Oliver Bechter
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From7 May 2012 → Today
Projects
1 - 5 of 5
- Dissecting the heterotypic cell communication networks at the perivascular niche to detect andintercept the early metastatic processFrom1 Jan 2023 → TodayFunding: BOF - iBOF
- Multiplexed immunohistochemistry and digital pathology as the foundation for next-generation pathology in melanoma researchFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Next-generation pathology by MILAN: multiplex immunohistochemistry and advanced trainable image analysisFrom1 Jan 2020 → 31 Dec 2021Funding: IOF - technology validation in lab
- Preventing therapy-induced cancer stemnessFrom1 Oct 2019 → TodayFunding: IOF - technology concept exploration, BOF - projects
- Treating melanoma as an infectious diseaseFrom1 Sep 2018 → 31 Aug 2022Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 75
- The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity(2023)
Authors: Oliver Bechter, Chris Marine
Pages: 1207 - + - CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours(2023)
Authors: Francesca Bosisio, Oliver Bechter, Chris Marine
Pages: 1033 - + - Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study(2023)
Authors: Christophe Deroose, Annouschka Laenen, Dietmar Thal, Oliver Bechter, Paul Clement
Pages: 480 - 487 - Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy(2023)
Authors: Ali Talebi, Vincent de Laat, Xander Spotbeen, Jonas Dehairs, Ginevra Doglioni, David Nittner, Tania Roskams, Patrizia Agostinis, Oliver Bechter, Maria Garmyn, et al.
- Multiomics and spatial mapping characterizes human CD8+T cell states in cancer(2023)
Authors: Stefan Naulaerts, Julie Messiaen, Isaure Vanmeerbeek, Jenny Sprooten, Dena Panovska, Lendert Gelens, Tom Venken, Oliver Bechter, Gabriele Bergers, Steven De Vleeschouwer, et al.
- [F-18] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [I-123] MIBG in neural crest tumour patients(2023)
Authors: Kristof Baete, Michel Koole, Oliver Bechter, Paul Clement, Koen Van Laere, Guy Bormans, Christophe Deroose
Pages: 1134 - 1145 - SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response(2022)
Authors: Ewout Landeloos, Yannick Van Herck, Oliver Bechter, Chris Marine
- Melanoma cell plasticity poses diagnostic challenges: a case series(2022)
Authors: Yannick Van Herck, Raf Sciot, Isabelle Vanden Bempt, Maria Garmyn, Oliver Bechter
Pages: 428 - 439 - Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy (vol 22, pg 108, 2021)(2022)
Authors: Jenny Sprooten, Oliver Bechter, Sabine Tejpar, Abhishek Garg
Pages: 260 - 260 - A cellular hierarchy in melanoma uncouples growth and metastasis (vol 610, pg 190, 2022)(2022)
Authors: Panagiotis Karras, Joanna Poźniak, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, Joost van den Oord, et al.
Pages: E4 - E4